Showing results (2931-2940 of 3,371) with videos related to

Sort By:
Pageof 338
ESC Heart Failure|June 19, 2021
Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosisTatsuya Akatsuka, Naoki Fujimoto, Masaki Ishiyama, et al.
ESC Heart Failure|July 16, 2021
WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort studyAtsuhiko Kawabe, Takanori Yasu, Takeshi Morimoto, et al.
ESC Heart Failure|July 10, 2021
Standardized gait speed ratio in elderly patients with heart failureTetsuya Ozawa, Masashi Yamashita, Satoshi Seino, et al.
ESC Heart Failure|May 23, 2022
Sex differences in efficacy of pharmacological therapies in heart failure with reduced ejection fraction: a meta-analysisCecilia Danielson, Gabriele Lileikyte, Wouter Ouwerkerk, et al.
ESC Heart Failure|May 13, 2022
Thirst in stable heart failure patients; time to reconsider fluid restriction and prescribed diureticsMartje H L van der Wal, Tiny Jaarsma, Lieset C Jenneboer, et al.
ESC Heart Failure|May 13, 2022
Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillationYu-Sheng Lin, Jeng-Yu Jan, Jung-Jung Chang, et al.
ESC Heart Failure|May 26, 2022
Fulminant necrotizing eosinophilic myocarditis after COVID-19 vaccination survived with mechanical circulatory supportMitsukuni Kimura, Toru Hashimoto, Eri Noda, et al.
ESC Heart Failure|May 27, 2022
Role of depressive symptoms in the prognosis of heart failure and its potential clinical predictorsJiahao Duan, Kai Huang, Xinying Zhang, et al.
ESC Heart Failure|May 28, 2022
Phenylacetylglutamine as a risk factor and prognostic indicator of heart failureXiao Zong, Qin Fan, Qian Yang, et al.
ESC Heart Failure|May 15, 2022
Heart failure ejection fraction class conversions: impact of biomarkers, co-morbidities, and pharmacotherapyChristian J Lorenzo, Jorge I Conte, Ricardo J Villasmil, et al.
Pageof 338